Utilization of over-the-counter analgesics in two private medical insurance schemes in South Africa.
Neelaveni PadayacheeAlan D RothbergIlse TruterNeil ButkowPublished in: Drug, healthcare and patient safety (2019)
Among the privately-insured individuals studied, the avaiIability, cost and formulation of N02BE51 OTC products appeared to be poorly regulated, whether by the consumer, pharmacist, medical insurance scheme or legislation. Doctors demonstrate better cost containment by prescribing less costly, smaller pack-size alternatives compared to pharmacists.